In their recent study, Mathew et al. showcased that strong T and B cell activation and proliferation observed in a subset of COVID19 patients was durable and that the relative clinical lymphopenia was preferential for CD8 T cells with a lesser effect on CD4 T cells and almost no impact on B cells [18]. Here, CD4 is linked to lymphopenia.